Medical Leadership Across the Development Lifecycle
Medical Affairs at Evestia Clinical provides the physician-led oversight and scientific strategy that complex clinical development programs require. Our medical directors and medical monitors bring direct therapeutic expertise to protocol design, patient safety monitoring and regulatory interaction.
Integrated with Clinical Operations, Project Management, Pharmacovigilance and Regulatory Affairs, our medical teams ensure clinical, scientific and operational decisions are aligned throughout the program.
Physician Oversight for Patient Safety and Clinical Integrity
Our medical monitors provide physician oversight throughout study conduct, supporting patient safety, protocol compliance and informed clinical decision-making.
Patient Safety
Physician oversight of patient safety throughout the study, including adverse event review, safety signal identification and clinical decision support.
Eligibility Review
Medical review of patient eligibility to ensure protocol compliance and appropriate enrollment.
Protocol Interpretation
Clarification of protocol requirements, medical queries and clinical decision-making for site teams.
Emerging Safety Information
Assessment and communication of emerging safety information to sponsors, investigators and ethics committees.
Medical and Scientific Input Throughout Development
Our medical directors contribute therapeutic and clinical expertise to development strategy, study design and regulatory planning from early development through post-marketing.
Clinical Development Strategy
Medical and scientific input into overall development strategy, study sequencing and regulatory pathway planning.
Endpoint Selection
Medical input into clinically meaningful endpoints, biomarkers and assessment tools.
Therapeutic Expertise
Disease-specific medical knowledge applied to protocol design, patient population selection and safety monitoring.
Regulatory Interaction Support
Medical input supporting health authority interactions, scientific advice and response preparation.
Medical Input Into Protocol Development and Study Conduct
Our medical teams contribute clinical and therapeutic expertise to protocol design, eligibility criteria, endpoint selection and ongoing study conduct to ensure scientifically robust and operationally feasible studies.
Protocol development and review
Eligibility criteria refinement
Endpoint and assessment definition
Study conduct medical oversight
Medical monitoring plan development
Safety review committee support
Medical Review of Safety Data and Clinical Findings
Our medical monitors conduct ongoing medical review of safety data, laboratory findings and adverse events to identify trends, assess clinical significance and support benefit-risk evaluation.
Safety Data Review
Ongoing medical review of safety data, laboratory findings and adverse events.
Adverse Event Assessment
Medical assessment of adverse events, including causality, severity and expectedness.
Laboratory Review
Medical review of laboratory abnormalities and clinical trends.
Emerging Clinical Information
Assessment of emerging clinical information and safety signals across the program.
Integrated Safety Surveillance and Benefit-Risk Support
Medical Affairs works closely with Pharmacovigilance to ensure safety surveillance is clinically informed throughout development and into the post-marketing period.
Our medical monitors contribute to benefit-risk assessment, safety review committee support and the medical evaluation that strengthens Phase IV and post-marketing safety programs.
Safety signal medical assessment
Benefit-risk evaluation support
Safety review committee participation
Post-marketing safety surveillance
Risk management plan medical input
Medical Leadership Across Integrated Teams
Medical Affairs does not operate in isolation. Our medical directors and monitors work alongside Project Management, Clinical Operations, Pharmacovigilance, Regulatory Affairs, Biostatistics and Medical Writing to ensure clinical, scientific and operational decisions are aligned.
Physician-Led Expertise
Our medical directors bring direct clinical and research experience to support sponsors across therapeutic areas and development phases.
Mónica Reale, MD
Senior Medical Director
Mónica is a medical oncologist with over 30 years of experience in clinical and oncology research. Her expertise covers nearly all solid tumors, hematological malignancies and bone marrow transplantation, with extensive experience in medical monitoring of Phase I–IV & Post-Marketing oncology trials.
Jennifer Prichard, MD
Medical Director
Dr. Prichard brings over a decade of experience in clinical research and drug development, providing medical oversight across all phases with a particular focus on neurodegenerative diseases and pediatric research.
Additional medical expert profiles can be added as approved information becomes available.